Evidence map›Paper›PMID 29580143›Full record

ArticleCancer biology & therapy2018

MiR-135a-5p represses proliferation of HNSCC by targeting

Lei-Ming Guo, Gao-Feng Ding, Wencai Xu, Hong Ge, Yue Jiang, Xi-Juan Chen, Yufei Lu

Open access · bronzeAbstract read
In one paragraph

Article in Cancer biology & therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Oncology letters · 2022
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Lei-Ming Guoa Department of Radiotherapy , Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital , Zhengzhou 450000 , Henan , China.
Gao-Feng Dinga Department of Radiotherapy , Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital , Zhengzhou 450000 , Henan , China.
Wencai Xua Department of Radiotherapy , Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital , Zhengzhou 450000 , Henan , China.
Hong Gea Department of Radiotherapy , Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital , Zhengzhou 450000 , Henan , China.
Yue Jianga Department of Radiotherapy , Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital , Zhengzhou 450000 , Henan , China.
Xi-Juan Chena Department of Radiotherapy , Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital , Zhengzhou 450000 , Henan , China.
Yufei Lua Department of Radiotherapy , Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital , Zhengzhou 450000 , Henan , China.
Henan Cancer Hospital · CNZhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HNSCCmiR-135a-5pmiR-494

Identifiers

PMID29580143
PMCPMC6301828
OpenAlexW2795344127

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.